Randomized Trial to Improve Prescribing Safety During Pregnancy

Journal of the American Medical Informatics Association

Volumn 14, Issue 4, 2007, Pages 440-450

  Raebel, Marsha A ^a,b   Carroll, Nikki M ^a   Kelleher, Julia A ^b,c   Chester, Elizabeth A ^b,c   Berga, Sally ^d   Magid, David J ^a,b  

^a CLINICAL RESEARCH UNIT   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c KAISER PERMANENTE   (United States)

^d University of Colorado Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOMIFENE CITRATE; CODEINE; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; LITHIUM CARBONATE; MISOPROSTOL; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PROGESTERONE; PROPYLTHIOURACIL; RETINOIC ACID; RETINOIC ACID DERIVATIVE; WARFARIN;

ARTICLE; DRUG CONTRAINDICATION; DRUG SAFETY; INFORMATION SYSTEM; INTERVENTION STUDY; LABORATORY DIAGNOSIS; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; RANDOMIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHI-SQUARE DISTRIBUTION; CLINICAL PHARMACY INFORMATION SYSTEMS; DRUG THERAPY, COMPUTER-ASSISTED; DRUG TOXICITY; FEMALE; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION ERRORS; MIDDLE AGED; PREGNANCY; PRESCRIPTIONS, DRUG; REMINDER SYSTEMS;

EID: 34250786843     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1197/jamia.M2412     Document Type: Article

References (37)

1. Mitchell A.A. Systematic identification of drugs that cause birth defects-A new opportunity. N Engl J Med 349 (2003) 2556-2559
2. Lo W.Y., and Friedman J.M. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 100 (2002) 465-472
3. Koren G., Pastuszak A., and Ito S. Drugs in pregnancy. N Engl J Med 338 (1998) 1128-1137
4. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitor. N Engl J Med 354 (2006) 2443-2451
5. Briggs G.G., Freeman R.K., and Yaffe S.J. Drugs in Pregnancy and Lactation. 6th ed. (2002), Lippincott Williams & Wilkins, Philadelphia
6. Malm H., Martikainen J., Klaukka T., and Neuvonen P. Prescription of hazardous drugs during pregnancy. Drug Saf 27 (2004) 899-908
7. Andrade S.E., Gurwitz J.H., Davis R.L., et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 191 (2004) 398-407
8. Lacroix I., Damase-Michel C., Lapeyre-Mestre M., and Montastruc J.L. Prescription of drugs during pregnancy in France. Lancet 356 (2000) 1735-1736
9. Cooper W.O., Hickson G.B., and Ray W.A. Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinatal Epidemiol 18 (2004) 106-111
10. Olesen C., Sorensen H.T., de Jong-van den Berg L., Olsen J., Steffensen F.H., and Euromap Group. Prescribing during pregnancy and lactation with reference to the Swedish classification system: A population-based study among Danish women. Acta Obstetricia et Gynecologica Scandinavica 78 (1999) 686-692
11. Schirm E., Meijer W.M., Tobi H., and de Jong-van den Berg L. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol 114 (2004) 182-188
12. Bates D.W., Boyle D.L., VanderVliet M.B., Schneider J., and Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 10 (1995) 199-205
13. Miller R.A., Waitman L.R., Chen S., and Rosenbloom S.T. The anatomy of decision support during inpatient care provider order entry (CPOE): Empirical observations from a decade of CPOE experience at Vanderbilt. J Biomed Inform 38 (2005) 469-485
14. Bates D.W., Leape L.L., Cullen D.J., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280 (1998) 1311-1316
15. Preventing Medication Errors (2006), Institute of Medicine of the National Academies Press, Washington, D.C
16. Agency for Health care Research and Quality. Advances in Patient Safety: From Research to Implementation (2005), Agency for Health care Research and Quality, Rockville, MD (Volumes 1-4)
17. Leape L.L., Cullen D.J., Clapp M.D., et al. Pharmacists participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282 (1999) 267-270
18. Schiff G.D., Klass D., Peterson J., Shah G., and Bates D.W. Linking laboratory and pharmacy: Opportunities for reducing errors and improving care. Arch Intern Med 163 (2003) 893-900
19. Gandhi T.K., Weingart S.N., Borus J., et al. Adverse drug events in ambulatory care. N Engl J Med 348 (2003) 1556-1564
20. IOM (Institute of Medicine). Preventing Medication Errors (2006), Institute of Medicine of the National Academies Press, Washington, D.C
21. Weingart S.N., Toth M., Sands D.Z., Aronson M.D., Davis R.B., and Phillips R.S. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 163 (2003) 2625-2631
22. Gandhi T.K., Weingart S.N., Seger A.C., et al. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med 20 (2005) 837-841
23. Raebel M.A., Charles J., Dugan J., et al. Randomized trial to improve prescribing safety among ambulatory elderly patients. J Am Geriatr Soc (2007) In press.
24. Witt D.M., Sadler M.A., Shanahan R.L., Mazzoli G., and Tillman D.J. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 127 (2005) 1515-1522
25. Raebel M.A., Lyons E.E., Bodily M.A., et al. Improving laboratory monitoring at initiation of drug therapy: A randomized trial. Arch Intern Med 165 (2005) 2395-2401
26. Raebel M.A., Chester E.A., Newsom E.E., et al. Randomized trial to improve laboratory safety monitoring of drug therapy in ambulatory patients. Pharmacotherapy 26 (2006) 619-626
27. Koppel R., Metlay J.P., Cohen A., et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 293 (2005) 1197-1203
28. Massaro T.A. Introducing physician order entry at a major academic medical center: I. Impact on organizational culture and behavior. Acad Med 68 (1993) 20-25
29. Van der Sijs H., Aarts J., Vulto A., and Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13 (2006) 138-147
30. Andrade S.E., Raebel M.A., Morse A.N., et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 15 (2006) 546-554
31. Raebel M.A., Lyons E.E., Chester E.A., et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: A randomized trial. Arch Intern Med 165 (2005) 2395-2401
32. Raebel M.A., Chester E.A., Newsom E.E., et al. Randomized trial to improve laboratory safety monitoring of drug therapy in ambulatory patients. Pharmacother 26 (2006) 619-626
33. Raebel M.A., Ellis J.L., and Andrade S.E. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf 14 (2005) 829-836
34. Peng C.C., Glassman P.A., Marks I.R., Fowler C., Castiglione B., and Good C.B. Retrospective drug utilization review: Incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. J Manag Care Pharm 9 (2003) 513-522
35. Hazlet T.K., Lee T.A., Hansten P.D., and Horn J.R. Performance of community pharmacy drug interaction software. J Am Pharm Assoc 41 (2001) 161-165
36. Abarca J., Colon L.R., Wang V.S., Malone D.C., Murphy J.E., and Armstrong E.P. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. J Manag Care Pharm 12 (2006) 383-389
37. Ballentine A.J., Kinnaird D., and Wilson J.P. Prescription errors occur despite computerized prescriber order entry. Am J Health Syst Pharm 60 (2003) 708-709